BreakThrough Digest offers current medical news and health articles on medical breakthroughs, medical research and health information on clinical trials,
cancer, Alzheimer's, stem-cell research, heart disease, diabetes and more.
Neprinol - exclusive distributors of pharmaceutical-grade products including neprinol, syntol, and devacor
Chelation - cardio renew is 100% pure edta providing cardiovascular cleansing by oral chelation.
Conjunctivitis- Treatments & Research in the News
QLT Announces Fourth Quarter and Year End 2009 Results - Phramalive.com For the fourth quarter of 2009, expenditures for Research and Development (R&D) were $8.1 ... patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual ...
InSite Vision Reports Full Year and Fourth Quarter 2009 ... - TMCnet Recent Accomplishments and Events Prescriptions of AzaSite (azithromycin ophthalmic solution) 1%, for the treatment of bacterial conjunctivitis, increased ... AzaSite for the treatment of blepharitis, an ocular disease characterized by inflammation ...
QLT Inc. Q4 2009 Earnings Call Transcript - Seekingalpha.com ... and for 2009 and also importantly give you an update on our research ... allergic conjunctivitis, and the overall allergic conjunctivitis market is large. It’s about 50 million people just in the US who suffer from allergic disease.
BreakThrough Digest Copyright 2007 BreakThrough Digest BreakThrough Digest subscribes to the eHealth Code of Ethics
medical new and medical breakthroughs health information and health articles about medicine on cancer, heart disease, diabetes and stem cell research
